Pneumothorax as a Poor Prognostic Indicator in Covid-19 in Turkey: a Propensity Score Matching Analysis

Loading...
Publication Logo

Date

2024

Journal Title

Journal ISSN

Volume Title

Publisher

Wolters Kluwer Medknow Publications

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

Research Projects

Journal Issue

Abstract

Background: Spontaneous pneumothorax in COVID-19 occurs infrequently but in up to 15% of patients dependent on mechanical ventilation (MV). Pneumothorax-related deaths account for 1% of all COVID-19-related deaths. Aim: To determine factors associated with pneumothorax in COVID-19 patients and the effect of pneumothorax on early survival. Methods: This was a retrospective study of 4799 COVID-19-positive hospitalized patients. The groups were homogenized using propensity score matching (PSM) in two groups comprising 67 COVID-19 patients each. The prevalence of pneumothorax was determined. Multiple logistic regression was used to determine factors associated with pneumothorax. P value < 0.05 was taken as significant. Results: The prevalence of pneumothorax in COVID-19 patients was 1.6%. Lung disease, comorbidities, and oxygen support, which were significantly different between the two groups before PSM, were homogenized after PSM. In a univariate analysis, symptom duration (P 0.001), neutrophilia (P 0.001), lymphopenia (P 0.001), neutrophil-lymphocyte ratio (P = 0.003), ferritin levels (P = 0.012), D-dimer levels (P = 0.011), MV support (P 0.001), antibiotherapy (P 0.001), length of hospital stay (P = 0.009), and death (P = 0.002) differed significantly between the groups. Pneumothorax had a significant negative effect on survival (32.8% vs. 59.7%, P = 0.01). In a multivariate regression model, factors associated with pneumothorax were duration of symptoms (Adjusted Odds ratio (AOR) 1.68; 95% Confidence Interval (CI): 1.26-2.25; P = 0.001), mechanical ventilation (AOR 23.92; 95% CI: 4.12-138.72; P = <0.001), dual antibiotics (AOR 8.28; 95% CI: 1.56-43.86; P = 0.013), neutrophilia (AOR: 1.08; 95% CI: 1.02-1.14; P = 0.011), and lymphopenia (AOR: 0.92; 95% CI: 0.86-0.90; P = 0.022). Conclusion: The presence of pneumothorax was associated with poor survival in COVID-19 patients. Patients with a prolonged time from symptom onset to treatment and those dependent on mechanical ventilation in intensive care were in the high risk group for the development of pneumothorax. Copyright © 2024 Nigerian Journal of Clinical Practice.

Description

Keywords

COVID-19; pneumothorax; prognostic factors; survival, Adult; Aged; Comorbidity; COVID-19; Female; Humans; Male; Middle Aged; Pneumothorax; Prevalence; Prognosis; Propensity Score; Respiration, Artificial; Retrospective Studies; Risk Factors; SARS-CoV-2; Turkey; adult; aged; artificial ventilation; comorbidity; complication; coronavirus disease 2019; epidemiology; female; human; male; middle aged; mortality; pneumothorax; prevalence; prognosis; propensity score; retrospective study; risk factor; Severe acute respiratory syndrome coronavirus 2; turkey (bird), Male, Adult, Turkey, SARS-CoV-2, COVID-19, Pneumothorax, Comorbidity, Middle Aged, Prognosis, Respiration, Artificial, Risk Factors, Prevalence, Humans, Female, COVID‑19, pneumothorax, prognostic factors, survival, Propensity Score, Retrospective Studies, Aged

Fields of Science

03 medical and health sciences, 0302 clinical medicine

Citation

WoS Q

Q3

Scopus Q

Q2
OpenCitations Logo
OpenCitations Citation Count
N/A

Source

Nigerian Journal of Clinical Practice

Volume

27

Issue

8

Start Page

958

End Page

964
PlumX Metrics
Citations

Scopus : 0

Captures

Mendeley Readers : 3

Page Views

1

checked on Mar 15, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.0

Sustainable Development Goals

SDG data could not be loaded because of an error. Please refresh the page or try again later.